D1 dopamine receptor antagonists as a new therapeutic strategy to treat autistic-like behaviours in lysosomal storage disorders
Maria De Risi(Telethon Institute Of Genetics And Medicine), Elvira De Leonibus(Institute of Genetics and Biophysics)
Cited by 1
Related Papers
Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes
|Frontiers in Neuroscience|2020|53
Phosphorylation of the AMPA receptor GluA1 subunit regulates memory load capacity
|Brain Structure and Function|2014|37
Altered heparan sulfate metabolism during development triggers dopamine-dependent autistic-behaviours in models of lysosomal storage disorders
|Nature Communications|2021|32
Synaptic mechanisms underlying onset and progression of memory deficits caused by hippocampal and midbrain synucleinopathy
|npj Parkinson s Disease|2023|15